These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 22493546)

  • 21. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma.
    Liu XH; Pan MH; Lu ZF; Wu B; Rao Q; Zhou ZY; Zhou XJ
    Dig Liver Dis; 2008 Jul; 40(7):560-7. PubMed ID: 18294932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of Wnt signaling pathway in keloid pathogenesis.
    Igota S; Tosa M; Murakami M; Egawa S; Shimizu H; Hyakusoku H; Ghazizadeh M
    Int J Med Sci; 2013; 10(4):344-54. PubMed ID: 23471552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
    J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ROR2 and Wnt5a expression in stage 1 pure testicular seminomas.
    Lim SD; Kim WS; Kwon GY
    Anal Quant Cytopathol Histpathol; 2013 Feb; 35(1):41-51. PubMed ID: 23469623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt-5a-Receptor Tyrosine Kinase-Like Orphan Receptor 2 Signaling Provokes Metastatic Colonization and Angiogenesis in Renal Cell Carcinoma, and Prunetin Supresses the Axis Activation.
    Chuang WY; Lee CW; Fan WL; Liu TT; Lin ZH; Wang KC; Huang PJ; Yeh YM; Lin TC
    Am J Pathol; 2024 Oct; 194(10):1967-1985. PubMed ID: 39069169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
    Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
    BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
    Hu BS; Xiong SM; Li G; Li JP
    Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
    Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma.
    Wang L; Yang D; Wang YH; Li X; Gao HM; Lv JY; Wang L; Xin SJ
    Tumour Biol; 2016 May; 37(5):6085-90. PubMed ID: 26608372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
    Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
    J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
    Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression levels of Wnt5a and Ror2 in laryngeal squamous cell carcinoma are associated with poor prognosis.
    Zhang W; Yan Y; Gu M; Wang X; Zhu H; Zhang S; Wang W
    Oncol Lett; 2017 Aug; 14(2):2232-2238. PubMed ID: 28781662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization.
    Nishita M; Itsukushima S; Nomachi A; Endo M; Wang Z; Inaba D; Qiao S; Takada S; Kikuchi A; Minami Y
    Mol Cell Biol; 2010 Jul; 30(14):3610-9. PubMed ID: 20457807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
    Liu Y; Rubin B; Bodine PV; Billiard J
    J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher expression level of tyrosine kinase-like orphan receptor 2 and Wnt member 5a in papillary thyroid carcinoma is associated with poor prognosis.
    Chen L; Zhao L; Ding M; Yang M; Yang W; Cui G; Shan B
    Oncol Lett; 2017 Nov; 14(5):5966-5972. PubMed ID: 29113233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.